Metabolic Biomarker and Kinase Drug Target Discovery in Cancer Using Stable Isotope-Based Dynamic Metabolic Profiling (SIDMAP)

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|3|6|445-453

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.3, Iss.6, 2003-12, pp. : 445-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic profiling technologies for biomarker discovery in biomedicine and drug development

By Schlotterbeck Götz   Ross Alfred   Dieterle Frank   Senn Hans  

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 1055-1075

Future Medicine

Access to resources Recommend Favorite

Medicinal Chemistry, Metabolic Profiling and Drug Target Discovery: A Role for Metabolic Profiling in Reverse Pharmacology and Chemical Genetics

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 1, 2005-01 ,pp. : 13-20

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand-directed profiling: applications to target drug discovery in cancer

By Staquicini Fernanda I   Pasqualini Renata   Arap Wadih  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 51-59

Informa Healthcare

Access to resources Recommend Favorite

Activity-Based Protein Profiling: Applications to Biomarker Discovery, In Vivo Imaging and Drug Discovery

By Alicia B. Berger   Phillip M. Vitorino   Matthew Bogyo  

American Journal of PharmacoGenomics, Vol. 4, Iss. 6, 2004-01 ,pp. : 371-381

Adis International

Access to resources Recommend Favorite

Metabolic Stability Screen for Drug Discovery Using Cassette Analysis and Column Switching

By  

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 67-72

Bentham Science Publishers

Access to resources Recommend Favorite